Healthcare News

RIAD, Saudi-Arabien, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSH) hat in seinem Krankenhaus in Riad ein eigenes Herzkatheterlabor innerhalb der...

RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 75 % la durée d’attente médiane aux urgences de son établissement...

RIAD, Saudi-Arabien, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSH) hat die mittlere Verweildauer in der Notaufnahme seines Krankenhauses in Riad um...

RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 46,4 % les hospitalisations pour insuffisance cardiaque décompensée...

RIAD, Saudi-Arabien, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSH) hat die Zahl der Krankenhauseinweisungen aufgrund einer dekompensierten...

Revenue growth at 9.0% in Q3, +7.2% at constant currency Group revenue +9.0% to Euro 7,486 million in Q3, +7.2% at constant ER1 on top of double-digit growth of last yearGroup revenue +6.8% to Euro...

Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants Chiffre d’affaires du Groupe en hausse de +9,0 %, à 7 486 millions d’euros au T3, +7,2 % à taux de change...

Fatturato in crescita del 9,0% nel terzo trimestre, +7,2% a cambi costanti Fatturato del terzo trimestre in crescita del 9,0% a 7.486 milioni di Euro, +7,2% a cambi costanti¹, dopo la crescita a...

Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETsSeparate independent,...

Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETsSeparate independent,...